Regency Centers Corporation
NASDAQ:REGREIT - Retail
-$1.53 today
- Market cap
- $13.77B
- Beta
- 0.83
- P/E (TTM)
- 22.5
- EPS (TTM)
- $3.43
- Dividend yield
- 3.84%
Volume 1.74M
Average 1.53M
REG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Regency Centers CorporationNASDAQ: REG
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How REG compares with its peers on the latest reported figures
- REG's LTM Jun 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for REG, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding REG) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for REG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.27B | 1.37B | 1.5B | 1.55B |
| Cost of Revenue | 326.68M | 345.94M | 394.77M | 433.05M | 860.07M |
| Gross Profit | 877.19M | 925.16M | 975.08M | 1.07B | 694.11M |
| Gross Margin | 72.9% | 72.8% | 71.2% | 71.2% | 44.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 78.22M | 79.9M | 97.81M | 101.47M | 118.54M |
| Operating Expenses | 78.22M | 79.9M | 97.81M | 101.47M | 118.54M |
| Depreciation & Amortization | 280.4M | 298.7M | 323.15M | 372.01M | 382.75M |
| EBITDA | 771.32M | 818.05M | 839.58M | 939.75M | 1.11B |
| EBITDA Margin | 64.1% | 64.4% | 61.3% | 62.5% | 71.5% |
| Operating Income | 798.97M | 845.25M | 877.27M | 968.77M | 575.57M |
| Operating Margin | 66.4% | 66.5% | 64.0% | 64.4% | 37.0% |
| Interest Income | 624K | 947K | 1.97M | 9.63M | 7.69M |
| Interest Expense | 145.36M | 146.19M | 155.78M | 189.02M | 211.98M |
| Other Income / Expenses | (431.64M) | (357.26M) | (505.51M) | (554.39M) | (59.08M) |
| Income Before Tax | 367.33M | 488M | 371.76M | 414.39M | 516.49M |
| Pre-Tax Margin | 30.5% | 38.4% | 27.1% | 27.6% | 33.2% |
| Income Tax Expense | 1.04M | (39K) | 895K | 4.55M | 0 |
| Net Income | 361.41M | 482.87M | 364.56M | 400.39M | 527.46M |
| Net Margin | 30.0% | 38.0% | 26.6% | 26.6% | 33.9% |
| EPS (Basic) | 2.12 | 2.81 | 2.04 | 2.11 | 2.82 |
| EPS (Diluted) | 2.12 | 2.81 | 2.04 | 2.11 | 2.82 |
| Weighted Avg Shares | 170.48M | 171.79M | 176.37M | 183.04M | 182.23M |
| Weighted Avg Shares (Diluted) | 170.69M | 171.79M | 176.37M | 183.04M | 182.23M |
Regency Centers Corporation
NASDAQ:REG
Intrinsic Alpha fair value
Locked
Current Price
$75.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.